Other diseases
Coronary heart disease in Luoyang
洛阳 冠心病
1 hospital in Luoyang
Order: papers led on coronary heart disease, 2021–2025, then A–Z. Research activity, not a rating of care.
Only hospitals listed for coronary heart disease: those with enough papers or registered trials on it in the records this site uses. Other hospitals in Luoyang may also treat it. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first.
- 3 papers ledNo open trial led
Coronary heart disease in every city Luoyang on the disease page, with the national map
open trials on coronary heart disease with a hospital in Luoyang
Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 18 Nov 2026, with a listed hospital in Luoyang as lead sponsor or study site. 0 of them are led by a hospital in Luoyang. Check the registry for the current status. Whether someone can take part is decided by the study team.
Only trials registered on ClinicalTrials.gov are counted. Trials registered only in China’s own registry (ChiCTR) are not.
- RecruitingEffectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease
- Phase
- N/A
- Started
- 2025-08
- Posted
- Registry
- NCT07031531
Age 18 years to 45 years (registered criteria)
Lead sponsor is not a listed hospital; 11 listed hospitals as study sitesBeijing, Hangzhou, Hefei, Luoyang, Luzhou, Nanjing, Shijiazhuang, Xi'an, Yangzhou, Zhengzhou
- RecruitingClinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occlusion Lesions
- Phase
- N/A
- Started
- 2025-04
- Posted
- Registry
- NCT07463664
Age 18 years to 80 years (registered criteria)
Led by First Affiliated Hospital of Zhengzhou University; 4 listed hospitals as study sitesBeijing, Luoyang, Xinxiang, Zhengzhou
- Not yet recruitingOptimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
- Phase
- N/A
- Started
- 2021-09
- Posted
- Registry
- NCT04995159
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 67 listed hospitals as study sitesBeijing, Bengbu, Changchun, Changsha, Chongqing, Guangzhou, Guiyang, Haikou, Hangzhou, Harbin, Hefei, Huai'an, Jinan, Kunming, Lanzhou, Luoyang, Nanchang, Nanjing, Nanning, Qingdao, Shanghai, Shantou, Shijiazhuang, Taiyuan, Tianjin, Wuhan, Xi'an, Xuzhou, Yantai, Yinchuan, Zhanjiang, Zhengzhou, Zhongshan, Zhuhai, Zibo
Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.
Disease research in Luoyang
Each number is papers led on that disease, 2021–2025. “Open” counts open trials the hospital leads. Hospitals A–Z; this is not a ranking.
A blank cell means no papers or trials were found in these records. It does not mean the hospital does not treat that disease.
| Cancer | Blood disorders | Other diseases | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital | Nasopharyngeal carcinoma | Oesophageal squamous cell carcinoma | Hepatocellular carcinoma | Stomach cancer | Lung cancer | Pancreatic cancer | Breast cancer | Glioma | Hepatoblastoma | Retinoblastoma | Chordoma | Osteosarcoma | Gastrointestinal stromal tumour | Neuroblastoma | Ewing sarcoma | Multiple myeloma | B-cell acute lymphoblastic leukaemia | Aplastic anaemia | Haemophagocytic lymphohistiocytosis | Lymphoma | Beta thalassaemia | Haemophilia A | Atypical haemolytic uraemic syndrome | Thrombotic thrombocytopenic purpura | Fanconi anaemia | Neuromyelitis optica spectrum disorder | IgG4-related disease | Myasthenia gravis | Moyamoya disease | Wilson disease | Biliary atresia | Coronary heart disease | Congenital heart disease | Scoliosis | Anti-NMDA receptor encephalitis | Takayasu arteritis | Hepatic echinococcosis | Idiopathic pulmonary fibrosis | Lymphangioleiomyomatosis | Amyotrophic lateral sclerosis | Spinal muscular atrophy | Fabry disease | Pompe disease | Duchenne muscular dystrophy | Behçet disease | Alport syndrome | IgA nephropathy | Gaucher disease | Niemann–Pick disease type C | Osteogenesis imperfecta | Primary biliary cholangitis | Primary sclerosing cholangitis | Congenital diaphragmatic hernia | Hirschsprung disease | Inherited epidermolysis bullosa | Hereditary angioedema | Familial adenomatous polyposis | Leber hereditary optic neuropathy | Majeed syndrome | NGLY1 deficiency | ISG15 deficiency | Shortlist |
| First Affiliated Hospital of Henan University of Science and Technology河南科技大学第一附属医院 | none | 182 open | none | 14 | 9 | 3 | 11 | none | none | 1 | none | 1 | none | 5 | none | none | 0 | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | 3 | none | none | none | 0 | none | 1 | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Luoyang Central Hospital, Zhengzhou University洛阳市中心医院 | none | none | none | none | none | none | none | none | none | 1 | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Luoyang Maternal and Child Health Hospital洛阳市妇幼保健院 | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | |
| Luoyang Orthopedic Hospital河南省洛阳正骨医院 | none | none | none | none | none | none | none | none | none | none | none | 4 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
Column labels are short names. Choose one to open that disease in Luoyang.
Other cities nearby
Straight-line distance from the city centre; counts are hospitals listed for coronary heart disease.
Counts are listed hospitals only, not every hospital in each city.
- 99 kmJiaozuo焦作None listed for coronary heart disease
- 106 kmZhengzhou郑州6 hospitals for coronary heart disease
- 140 kmYuncheng运城None listed for coronary heart disease
- 153 kmXinxiang新乡1 hospital for coronary heart disease
- 171 kmKaifeng开封None listed for coronary heart disease
- 178 kmNanyang南阳None listed for coronary heart disease
Where these numbers come from
Papers
English-language PubMed papers, 2021–2025, where the first or last author lists the hospital first. Definitions
Trials
ClinicalTrials.gov records with the hospital as lead sponsor or site, as of 8 Nov 2026. Search Luoyang on ClinicalTrials.gov
Locations
Locations are shown at city centres. Check the hospital’s website for its address.